同步左右 发表于 2025-3-23 09:51:50

Submitted on: 26 December 1998.
Revised on: 25 February 1999.
Accepted on: 07 April 1999.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

Regurgitation 发表于 2025-3-23 14:15:00

http://reply.papertrans.cn/1/94/9340/9340-12.png

NICHE 发表于 2025-3-23 18:10:29

Submitted on: 09 September 2005.
Revised on: 28 November 2005.
Accepted on: 17 December 2005.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

骚扰 发表于 2025-3-23 23:52:29

Submitted on: 05 June 2001.
Revised on: 11 August 2001.
Accepted on: 08 October 2001.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

CHAR 发表于 2025-3-24 03:48:17

http://reply.papertrans.cn/1/94/9340/9340-15.png

indenture 发表于 2025-3-24 09:23:04

Submitted on: 12 August 2004.
Revised on: 27 October 2004.
Accepted on: 23 December 2004.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

Biofeedback 发表于 2025-3-24 13:29:12

Submitted on: 30 July 2010.
Revised on: 06 October 2010.
Accepted on: 17 October 2010.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

微不足道 发表于 2025-3-24 16:22:53

http://reply.papertrans.cn/1/94/9340/9340-18.png

肌肉 发表于 2025-3-24 22:48:28

http://reply.papertrans.cn/1/94/9340/9340-19.png

有抱负者 发表于 2025-3-24 23:47:32

http://reply.papertrans.cn/1/94/9340/9340-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊EUROPEAN NEUROPSYCHOPHARMACOLOGY 2024/2025影响因子:6.196 (EUR NEUROPSYCHOPHARM) (0924-977X). (PHARMACOLOGY & PHARMACY